|
PTENP1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.66269994731294E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.77029999992584E-07 |
| Normal-vs-Stage2 |
6.2773000000016E-05 |
| Normal-vs-Stage3 |
4.16640000278079E-08 |
| Normal-vs-Stage4 |
2.02669999999072E-05 |
| Stage1-vs-Stage2 |
6.396200E-01 |
| Stage1-vs-Stage3 |
2.136600E-01 |
| Stage1-vs-Stage4 |
6.427200E-01 |
| Stage2-vs-Stage3 |
6.891600E-01 |
| Stage2-vs-Stage4 |
9.847200E-01 |
| Stage3-vs-Stage4 |
6.536400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
5.69920000081936E-08 |
| Normal-vs-AfricanAmerican |
7.634600E-04 |
| Normal-vs-Asian |
1.76500000004243E-06 |
| Caucasian-vs-AfricanAmerican |
9.081800E-01 |
| Caucasian-vs-Asian |
4.718800E-01 |
| AfricanAmerican-vs-Asian |
6.776200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.23040000305141E-08 |
| Normal-vs-Female |
5.36440000198368E-08 |
| Male-vs-Female |
4.399000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.92323999999022E-05 |
| Normal-vs-Age(41-60Yrs) |
1.30790001051651E-09 |
| Normal-vs-Age(61-80Yrs) |
1.24349999996998E-06 |
| Normal-vs-Age(81-100Yrs) |
1.268450E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.351600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.811800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.581400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.005000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.678000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.880400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.613800E-01 |
| Classical-VS-Follicular |
7.594200E-01 |
| Classical-VS-Other |
5.406200E-01 |
| Classical-VS-Normal |
5.68089999486432E-08 |
| Tall-VS-Follicular |
8.282400E-01 |
| Tall-VS-Other |
5.642400E-01 |
| Tall-VS-Normal |
1.223760E-03 |
| Follicular-VS-Other |
6.786200E-01 |
| Follicular-VS-Normal |
3.56000000000245E-05 |
| Other-VS-Normal |
1.686230E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.73459999089454E-09 |
| Normal-vs-N1 |
1.65210000013793E-07 |
| N0-vs-N1 |
5.705400E-01 |
|
|
